NEWSROOM

Pharmaceutical

PAOG Confirms Plans For First CBD Nutraceutical Revenue In 2021 Targeting $16 Billion Market

  Sandusky, OH, Sept. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a brief status update on the company’s ongoing initiatives to include confirming plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021. The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027. PAOG plans to...

read more

Nutra Pharma Provides Business and Compliance Updates

  Nutra Pharma is providing updates regarding their business plans, accounting and compliance   Plantation, Florida, July 26, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their...

read more

Nutra Pharma Engages Government Affairs Consulting Firm

  Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies   Plantation, Florida, July 15, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing...

read more

PAOG Targets $18 Billion Market Opportunity With New CBD Nutraceutical To Be Packaged By ALKM And Marketed By USMJ

  Sandusky, OH, June 24, 2021 – McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a CBD Nutraceuticals Business Development Update. PAOG expects to generate revenue this year from its CBD Nutraceuticals. PAOG’s CBD Nutraceuticals Business Development initiative is a complementary effort running in parallel to PAOG’s ongoing Pharmaceutical Developments. PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic...

read more

PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd

  Sandusky, OH, June 21, 2021 – McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceuticals Business Development Update scheduled for release this week, on Wednesday, June 23rd, 2021. PAOG plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021, is on track.  The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to...

read more

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of pain relief products to their marketplace Plantation, Florida, June 8, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet, and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...

read more

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

  Plantation, Florida, June 4, 2021 - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for increasing sales of their over-the-counter pain relievers through private-label agreements that will rebrand Nyloxin. The...

read more

Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief

  Nutra Pharma announces that professional snowboarder and wakeboarder, Jake Vedder, is endorsing Nyloxin for Chronic Pain Relief as part of their social media and influencer campaign   Plantation, Florida, June 2, 2021 -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

read more

PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

  Sandusky, OH, May 27, 2021 – McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today highlighted Alkame Holdings, Inc’s (OTC Pink: ALKM) recent news reporting the near completion status of its new production facility: ALKM – Alkame Confirms $15 Million Annual Revenue Bottling Production Potential PAOG recenlty released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the...

read more

Nutra Pharma Provides Updates on Improvements of Manufacturing Capabilities

Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for the production of their over-the-counter pain relievers   Plantation, Florida, May 27, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

read more

Nutra Pharma Announces Influencer and Social Media Campaign for Nyloxin and Pet Pain-Away

Nutra Pharma is announcing their newest marketing plans for their over-the-counter pain relievers will utilize influencers, celebrities and athletes on social media platforms   Plantation, Florida, May 24, 2021 -- McapMediaWire  -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

read more
PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market

PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market

  Sandusky, OH, May 13, 2021 –  -- PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027. That market value represents global sales.  PAOG management is targeting specific international segments to be included in its Q4 sales launch.  PAOG management anticipates a lower market...

read more

DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity

Dyadic International Inc (NASDAQ: DYAI) is in an interesting position, being one of the very few names in the anti-Covid space that offer a new path that isn’t simply a reproduction or tie-in to the big pharma game right now. DYAI has a new approach that isn’t new-age quote-unquote “science”, but a powerful new potential solution that holds the capacity to possibly become better able to deal with new variants and even possibly better able to drive cheap and efficient production capable of...

read more

PAOG Confirms CBD Nutraceutical Q4 Revenue Plans

  Sandusky, OH, May 11, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021. On Friday, PAOG released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments. PAOG is working on the development of a...

read more

PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution

  Sandusky, OH, May 7, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments. PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) derived from a...

read more

PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

  Sandusky, OH, May 5, 2021 – -- PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING...

read more

PAOG CBD Nutraceuticals To Hit Market This Year

  Sandusky, OH, May 4, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT...

read more

PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

  Sandusky, OH, May 3, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT...

read more

PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook

  Sandusky, OH, April 28, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in conjunction with PURA’s Farmersville Hemp Brand project in Texas.  PURA Farmersville Hemp Brand project partners also include Alkame Holdings,...

read more

Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com   Plantation, Florida, April 15, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that their newest product, Luxury...

read more

Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product

London, UK, April 14, 2021 – -- Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the launch of DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms (including Lion’s Mane), the tincture will be available for sale on the DailyLife CBD website as of today.       “It is my pleasure to announce that...

read more

Epidemiologic Solutions Corporation (ESC), an IRS approved, qualified public charity, announces its funding for its “pain-free-veterans” initiative

  Westlake, LA, April 14, 2021 - -  Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of PainplexTM an all-herbal extraction developed by Gold River Productions Services (GRPS) and other formulations.  This will be part of the “Relief Kit,” which will include products from both GRPS and Halberd...

read more

PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

  Sandusky, OH, April 13, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS...

read more

SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.

  Scottsdale, Arizona, April 12, 2021 - - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: Sibannac, Inc. and Stellar Chemical Corp. (“Stellar”), a New Jersey based nutraceutical and industrial chemical manufacturer, have entered into a Memorandum of Understanding for Sibannac to acquire 51% of Stellar in a stock and cash transaction. Stellar is currently profitable, grossing $4.5 Million in annual revenue from business to business as well as...

read more

PAOG Advances CBD Pharmaceutical Developments Backed By US Patent

  Sandusky, OH, April 8, 2021 – --  PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960...

read more

Gold River Productions, Inc. (GRPS) announces its initial product line for physicians and its newly-initiated physician-patient distribution network

  Palm Coast, FL, April 5, 2021, Gold River Productions, Inc. (OTC Pink: GRPS) announces today its initial product line for physicians and its newly-initiated physician-patient distribution network. With RushNet Inc.'s (OTC Pink: RSHN) recent acquisition of HeliosDX, the Company isfortunate to share an expanding network of physicians through whom they will be marketing most of their products. Its new CEO, Ashley Sweat, said “I look forward to introducing these products to the HeliosDx...

read more

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos   Plantation, Florida, March 16, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

read more

PURA and PAOG Confirm Ongoing And Expanding Cannabis Partnership

  Dallas, TX, March 11, 2021 - Puration, Inc. (OTC Pink: PURA) and PAOG Group, Inc. (OTC Pink: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through a partnership that initiated when PAOG acquired PURA’s cannabis cultivation business last year.     The PURA and PAOG partnership include a pending distribution of PAOG stock to PURA shareholders.  PURA shareholders are intended to receive one share of PAOG...

read more

Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

  Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials   Plantation, Florida,  March 11, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple...

read more

PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update

  Sandusky, OH, March 10, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North American Cannabis Holdings, Inc. (OTC Pink: USMJ). CBD RELAX-RX targets the anxiety and depression treatment market anticipated to reach a value of $18...

read more

Categories